<bill session="117" type="h" number="8428" updated="2022-12-29T18:18:46Z">
  <state datetime="2022-07-19">REFERRED</state>
  <status>
    <introduced datetime="2022-07-19"/>
  </status>
  <introduced datetime="2022-07-19"/>
  <titles>
    <title type="display">Allowing Greater Access to Safe and Effective Contraception Act</title>
    <title type="short" as="introduced">Allowing Greater Access to Safe and Effective Contraception Act</title>
    <title type="official" as="introduced">To allow women greater access to safe and effective oral contraceptive drugs intended for routine use.</title>
  </titles>
  <sponsor bioguide_id="H001091"/>
  <cosponsors>
    <cosponsor bioguide_id="A000377" joined="2022-07-21"/>
    <cosponsor bioguide_id="B000740" joined="2022-07-21"/>
    <cosponsor bioguide_id="B001257" joined="2022-07-21"/>
    <cosponsor bioguide_id="C000059" joined="2022-07-20"/>
    <cosponsor bioguide_id="H001056" joined="2022-07-20"/>
    <cosponsor bioguide_id="J000020" joined="2022-07-21"/>
    <cosponsor bioguide_id="M000194" joined="2022-07-19"/>
    <cosponsor bioguide_id="M000317" joined="2022-07-20"/>
    <cosponsor bioguide_id="M001199" joined="2022-07-21"/>
    <cosponsor bioguide_id="M001159" joined="2022-07-19"/>
    <cosponsor bioguide_id="M001215" joined="2022-07-19"/>
    <cosponsor bioguide_id="N000189" joined="2022-07-21"/>
    <cosponsor bioguide_id="O000019" joined="2022-07-20"/>
    <cosponsor bioguide_id="O000086" joined="2022-07-20"/>
    <cosponsor bioguide_id="S001195" joined="2022-07-19"/>
    <cosponsor bioguide_id="S001196" joined="2022-07-21"/>
    <cosponsor bioguide_id="V000133" joined="2022-07-21"/>
  </cosponsors>
  <actions>
    <action datetime="2022-07-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-07-19" state="REFERRED">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2022-07-19">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2022-07-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="s" number="4638" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-21T20:41:13Z" status="Introduced in House">Allowing Greater Access to Safe and Effective Contraception Act

This bill requires the Food and Drug Administration to prioritize review of supplemental applications for over-the counter oral contraceptives that are intended for routine use. It also removes certain limitations in relation to such products and health savings accounts, flexible spending arrangements, and other arrangements (e.g., limitations on the number of items that may be purchased).</summary>
</bill>
